New heart valve procedure could offer hope for patients with leaky tricuspid valve
Disease control
Not yet recruiting
This study tests a new device, the Medtronic Intrepid™ TTVR System, to replace the tricuspid valve without open-heart surgery in people with severe tricuspid regurgitation. About 1,186 participants will receive the valve and be followed for safety and quality of life. The goal is…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 01, 2026 23:14 UTC